Fluticasone propionate: Topical or systemic effects?

Clinical and Experimental Allergy, Supplement

Volumn 26, Issue 3, 1996, Pages 18-22

  Howland III, W C ^a  

^a HealthQuest Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; PLACEBO;

ADULT; ALLERGIC RHINITIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; CHILD; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNE SYSTEM; MALE; NASAL MUCOSA; PITUITARY-ADRENAL SYSTEM; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 0029893723     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Phillipps GH. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 1990; 84(Suppl A):19-23.
2. Johnson M. The anti-inflammatory profile of fluticasone propionate. Allergy 1995; 50(Suppl 23):11-14.
3. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84(Suppl A):25-9.
4. Meltzer EO, Orgel HA, Bronsky EA et al. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology. J Allergy Clin Immunol 1990; 86:221-30.
5. Van As A, Bronsky E, Grossman J, Meltzer E, Ratner P, Reed C. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy 1991; 67:156-62.
6. Nathan RA, Bronsky EA, Fireman P et al. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann Allergy 1991; 67:332-8.
7. Meltzer EO, Orgel HA, Rogenes PR, Field EA. Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate. J Allergy Clin Immunol 1994; 94:708-15.
8. Bronsky EA, Dockhorn R, Meltzer EO et al. Fluticasone propionate aqueous nasal spray compared with terfenadine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996 (in press).
9. Van Bavel J, Findlay SR, Hampel F et al. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med 1994; 154:2699-704.
10. Jordana G, Dolovich J, Briscoe M et al. Intranasal fluticasone propionate vs loratadine in the treatment of adolescent patients with seasonal allergic rhinitis (SAR). J Allergy Clin Immunol 1993; 91:196(Abstract).
11. Ramsdale EH, Kline PA. Comparison of once daily treatment with an antihistamine (loratadine) and topical steroid (fluticasone propionate) during the ragweed pollen season. J Allergy Clin Immunol 1991; 87:298(Abstract).
12. Banov CH, Woehler TR, LaForce CF et al. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis. Ann Allergy 1994; 73:240-6.
13. Van As A, Bronsky EA, Dockhorn RJ et al. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone dipropionate. J Allergy Clin Immunol 1993; 91:1146-54.
14. Lindqvist N, Anderson M, Bende M, Löth S, Pipkorn U. The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application. Clin Exper Allergy 1989; 19:71-6.
15. Hampel F, Howland W, Martin B et al. The efficacy of fluticasone propionate aqueous nasal spray for treatment of rhinitis is dependent on topical application. J Allergy Clin Immunol 1994; 93:165(Abstract).
16. Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med 1995; 98:196-208.
17. Li J, Lyles K, Halstenson C et al. Long-term safety study of fluticasone propionate aqueous nasal spray. Ann Allergy Asthma Immunol 1995; 74:58(Abstract).
18. Howland W, Field E, Harding S et al. Fluticasone propionate aqueous nasal spray is an antirhinitic with topical but not systemic activity. J Allergy Clin Immunol 1995; 95: 196(Abstract).